发明名称 |
IMPROVED HUMANIZED ANTI-HUMAN alpha9-INTEGRIN ANTIBODY |
摘要 |
<p>The present invention provides a humanized anti-human ±9 integrin antibody having improved activity and/or property as compared to donor mouse anti-human ±9 integrin antibody, namely, a humanized anti-human ±9 integrin antibody comprising a heavy-chain variable region consisting of the amino acid sequence shown by SEQ ID NO: 1 or the amino acid sequence shown by SEQ ID NO: 1 wherein one or several amino acids are substituted, deleted, inserted and/or added and a light-chain variable region consisting of the amino acid sequence shown by SEQ ID NO: 61 or the amino acid sequence shown by SEQ ID NO: 61 wherein one or several amino acids are substituted, deleted, inserted and/or added, as well as a means for preventing or treating various diseases involving human ±9 integrin in their pathogenesis, which uses the antibody.</p> |
申请公布号 |
EP2243829(B1) |
申请公布日期 |
2014.08.20 |
申请号 |
EP20090700904 |
申请日期 |
2009.01.09 |
申请人 |
ASTELLAS PHARMA INC. |
发明人 |
UEHARA, KENJI;HIGUCHI, HIROFUMI;NAKASHIMA, TOSHIHIRO;ISHIKAWA, DAISUKE;YAMAMOTO, NOBUCHIKA;FUJITA, HIROTADA;SAKAI, FUMIHIKO |
分类号 |
A61K39/395;A61P29/00;C07K16/28;C07K16/46 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|